Stocks
Silexion Therapeutics CorpSLXN
NASDAQHealthcareBiotechnology$0.19
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing RNA interference (RNAi) therapeutics for solid tumors, with a lead candidate targeting KRAS mutations in pancreatic cancer. Its stock is tracked for its pipeline progress and volatility around clinical trial data.
52W Range: $0.14-$35.60
Congressional Interest in Silexion Therapeutics Corp (SLXN)
No congressional trades have been disclosed for Silexion Therapeutics Corp (SLXN) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading SLXN?
No congressional trades found for this stock.